PubMed

Extracorporeal photopheresis for the prevention of acute GVHD in patients undergoing standard myeloablative conditioning and allogeneic hematopoietic stem cell transplantation.

Shaughnessy PJ, Bolwell BJ, van Besien K, Mistrik M, Grigg A, Dodds A, Prince HM, Durrant S, Ilhan O, Parenti D, Gallo J, Foss F, Apperley J, Zhang MJ, Horowitz MM, Abhyankar S.

Bone Marrow Transplant. 2009 Nov 16. [Epub ahead of print]PMID: 19915634 [PubMed - as supplied by publisher]Related articles

Reduced-intensity and nonmyeloablative conditioning regimens.

Foss F, van Besien K.

Cancer Treat Res. 2009;144:1-24. No abstract available. PMID: 19779868 [PubMed - in process]Related articles

Nutrient isothiocyanates covalently modify and inhibit the inflammatory cytokine macrophage migration inhibitory factor (MIF).

Cross JV, Rady JM, Foss FW, Lyons CE, Macdonald TL, Templeton DJ.

Biochem J. 2009 Oct 12;423(3):315-21.PMID: 19723024 [PubMed - indexed for MEDLINE]Related articles

Synthesis and biological evaluation of sphingosine kinase substrates as sphingosine-1-phosphate receptor prodrugs.

Foss FW Jr, Mathews TP, Kharel Y, Kennedy PC, Snyder AH, Davis MD, Lynch KR, Macdonald TL.

Bioorg Med Chem. 2009 Aug 15;17(16):6123-36. Epub 2009 Apr 12.PMID: 19632123 [PubMed - indexed for MEDLINE]Related articles

Cutaneous T-cell lymphoma.

Lansigan F, Choi J, Foss FM.

Hematol Oncol Clin North Am. 2008 Oct;22(5):979-96, x. Review.PMID: 18954747 [PubMed - indexed for MEDLINE]Related articles

Artificial enzymes with thiazolium and imidazolium coenzyme mimics.

Zhao H, Foss FW Jr, Breslow R.

J Am Chem Soc. 2008 Sep 24;130(38):12590-1. Epub 2008 Sep 3.PMID: 18763766 [PubMed - indexed for MEDLINE]Related articlesFree article

In vitro metabolism of a model cyclopropylamine to reactive intermediate: insights into trovafloxacin-induced hepatotoxicity.

Sun Q, Zhu R, Foss FW Jr, Macdonald TL.

Chem Res Toxicol. 2008 Mar;21(3):711-9. Epub 2008 Feb 26.PMID: 18298092 [PubMed - indexed for MEDLINE]Related articles

Mycosis fungoides: pathophysiology and emerging therapies.

Duvic M, Foss FM.

Semin Oncol. 2007 Dec;34(6 Suppl 5):S21-8. Review.PMID: 18086343 [PubMed - indexed for MEDLINE]Related articles

Follicular shuttling of marginal zone B cells facilitates antigen transport.

Cinamon G, Zachariah MA, Lam OM, Foss FW Jr, Cyster JG.

Nat Immunol. 2008 Jan;9(1):54-62. Epub 2007 Nov 25.PMID: 18037889 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy of denileukin diftitox in subcutaneous panniculitis-like T-cell lymphoma.

Hathaway T, Subtil A, Kuo P, Foss F.

Clin Lymphoma Myeloma. 2007 Sep;7(8):541-5.PMID: 18021473 [PubMed - indexed for MEDLINE]Related articles

Mechanisms of trovafloxacin hepatotoxicity: studies of a model cyclopropylamine-containing system.

Sun Q, Zhu R, Foss FW Jr, Macdonald TL.

Bioorg Med Chem Lett. 2007 Dec 15;17(24):6682-6. Epub 2007 Oct 24.PMID: 17976985 [PubMed - indexed for MEDLINE]Related articles

Phase II study of denileukin diftitox for previously treated indolent non-Hodgkin lymphoma: final results of E1497.

Kuzel TM, Li S, Eklund J, Foss F, Gascoyne R, Abramson N, Schwerkoske JF, Weller E, Horning SJ.

Leuk Lymphoma. 2007 Dec;48(12):2397-402. Epub 2007 Oct 13.PMID: 17943599 [PubMed - indexed for MEDLINE]Related articles

Efficacy of low dose clofarabine in refractory precursor T- acute lymphoblastic leukemia.

Choi J, Foss F.

Yale J Biol Med. 2006 Dec;79(3-4):169-72.PMID: 17940627 [PubMed - indexed for MEDLINE]Related articlesFree article

The isothiocyanate class of bioactive nutrients covalently inhibit the MEKK1 protein kinase.

Cross JV, Foss FW, Rady JM, Macdonald TL, Templeton DJ.

BMC Cancer. 2007 Sep 25;7:183.PMID: 17894894 [PubMed - indexed for MEDLINE]Related articlesFree article

Oxidation potentials correlate with conductivities of aromatic molecular wires.

Quinn JR, Foss FW Jr, Venkataraman L, Breslow R.

J Am Chem Soc. 2007 Oct 17;129(41):12376-7. Epub 2007 Sep 22. No abstract available. PMID: 17887757 [PubMed]Related articles

Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma.

Olsen EA, Kim YH, Kuzel TM, Pacheco TR, Foss FM, Parker S, Frankel SR, Chen C, Ricker JL, Arduino JM, Duvic M.

J Clin Oncol. 2007 Jul 20;25(21):3109-15. Epub 2007 Jun 18.PMID: 17577020 [PubMed - indexed for MEDLINE]Related articles

Single-molecule junction conductance through diaminoacenes.

Quinn JR, Foss FW Jr, Venkataraman L, Hybertsen MS, Breslow R.

J Am Chem Soc. 2007 May 30;129(21):6714-5. Epub 2007 May 9. No abstract available. PMID: 17488083 [PubMed]Related articles

Phase II trial of subcutaneous injections of human recombinant interleukin-2 for the treatment of mycosis fungoides and Sézary syndrome.

Querfeld C, Rosen ST, Guitart J, Rademaker A, Foss F, Gupta R, Kuzel TM.

J Am Acad Dermatol. 2007 Apr;56(4):580-3. Epub 2006 Nov 7.PMID: 17367611 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.

Whittaker SJ, Foss FM.

Cancer Treat Rev. 2007 Apr;33(2):146-60. Epub 2007 Feb 1. Review.PMID: 17275192 [PubMed - indexed for MEDLINE]Related articles

Biologic correlates of response and survival in patients with cutaneous T-cell lymphoma treated with denileukin diftitox.

Chin KM, Foss FM.

Clin Lymphoma Myeloma. 2006 Nov;7(3):199-204.PMID: 17229335 [PubMed - indexed for MEDLINE]Related articles

Synthesis and biological evaluation of gamma-aminophosphonates as potent, subtype-selective sphingosine 1-phosphate receptor agonists and antagonists.

Foss FW Jr, Snyder AH, Davis MD, Rouse M, Okusa MD, Lynch KR, Macdonald TL.

Bioorg Med Chem. 2007 Jan 15;15(2):663-77. Epub 2006 Nov 1.PMID: 17113298 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.

Duvic M, Sherman ML, Wood GS, Kuzel TM, Olsen E, Foss F, Laliberté RJ, Ryan JL, Zonno K, Rook AH.

J Am Acad Dermatol. 2006 Nov;55(5):807-13. Epub 2006 Sep 8.PMID: 17052486 [PubMed - indexed for MEDLINE]Related articles

The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.

Foss FM.

Semin Hematol. 2006 Apr;43(2 Suppl 2):S35-43. Review.PMID: 16549113 [PubMed - indexed for MEDLINE]Related articles

Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptoms.

Dummer R, Foss F, Dreno B, Bagot M.

Semin Oncol. 2006 Feb;33(1 Suppl 3):S26-32.PMID: 16516673 [PubMed - indexed for MEDLINE]Related articles

Immunomodulatory effects of rexinoids.

Foss F.

Semin Oncol. 2006 Feb;33(1 Suppl 3):S21-5. Review.PMID: 16516672 [PubMed - indexed for MEDLINE]Related articles

Clinical experience with denileukin diftitox (ONTAK).

Foss F.

Semin Oncol. 2006 Feb;33(1 Suppl 3):S11-6. Review.PMID: 16516670 [PubMed - indexed for MEDLINE]Related articles

CTCL: the most common type of primary cutaneous lymphoma: introduction.

Foss F, Whittaker S.

Semin Oncol. 2006 Feb;33(1 Suppl 3):S1-2. No abstract available. PMID: 16516667 [PubMed - indexed for MEDLINE]Related articles

Selective sphingosine 1-phosphate 1 receptor activation reduces ischemia-reperfusion injury in mouse kidney.

Awad AS, Ye H, Huang L, Li L, Foss FW Jr, Macdonald TL, Lynch KR, Okusa MD.

Am J Physiol Renal Physiol. 2006 Jun;290(6):F1516-24. Epub 2006 Jan 10.PMID: 16403835 [PubMed - indexed for MEDLINE]Related articlesFree article

Synthesis, stability, and implications of phosphothioate agonists of sphingosine-1-phosphate receptors.

Foss FW Jr, Clemens JJ, Davis MD, Snyder AH, Zigler MA, Lynch KR, Macdonald TL.

Bioorg Med Chem Lett. 2005 Oct 15;15(20):4470-4.PMID: 16125386 [PubMed - indexed for MEDLINE]Related articles

Activity of gallium nitrate in refractory peripheral T-cell lymphoma.

Huang Z, Higgins B, Foss F.

Clin Lymphoma. 2005 Jun;6(1):43-5.PMID: 15989706 [PubMed - indexed for MEDLINE]Related articles

Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.

Foss FM, DiVenuti GM, Chin K, Sprague K, Grodman H, Klein A, Chan G, Stiffler K, Miller KB.

Bone Marrow Transplant. 2005 Jun;35(12):1187-93.PMID: 15852025 [PubMed - indexed for MEDLINE]Related articles

A phase-1 trial of bexarotene and denileukin diftitox in patients with relapsed or refractory cutaneous T-cell lymphoma.

Foss F, Demierre MF, DiVenuti G.

Blood. 2005 Jul 15;106(2):454-7. Epub 2005 Apr 5.PMID: 15811959 [PubMed - indexed for MEDLINE]Related articlesFree article

Nucleoside analogs and antimetabolite therapies for myelodysplastic syndrome.

Foss FM.

Best Pract Res Clin Haematol. 2004 Dec;17(4):573-84. Review.PMID: 15494295 [PubMed - indexed for MEDLINE]Related articles

Mycosis fungoides and the Sézary syndrome.

Foss F.

Curr Opin Oncol. 2004 Sep;16(5):421-8. Review.PMID: 15314509 [PubMed - indexed for MEDLINE]Related articles

Overview of cutaneous T-cell lymphoma: prognostic factors and novel therapeutic approaches.

Foss F.

Leuk Lymphoma. 2003;44 Suppl 3:S55-61. Review.PMID: 15202526 [PubMed - indexed for MEDLINE]Related articles

A novel reduced intensity regimen for allogeneic hematopoietic stem cell transplantation associated with a reduced incidence of graft-versus-host disease.

Miller KB, Roberts TF, Chan G, Schenkein DP, Lawrence D, Sprague K, Gorgun G, Relias V, Grodman H, Mahajan A, Foss FM.

Bone Marrow Transplant. 2004 May;33(9):881-9.PMID: 14990986 [PubMed - indexed for MEDLINE]Related articles

Denileukin diftitox and hyper-CVAD in the treatment of human T-cell lymphotropic virus 1-associated acute T-cell leukemia/lymphoma.

Di Venuti G, Nawgiri R, Foss F.

Clin Lymphoma. 2003 Dec;4(3):176-8.PMID: 14715100 [PubMed - indexed for MEDLINE]Related articles

Novel agents for cutaneous T-cell lymphoma.

Kuzel TM, Junghans R, Foss FM.

Hematol Oncol Clin North Am. 2003 Dec;17(6):1459-66, x. Review.PMID: 14710896 [PubMed - indexed for MEDLINE]Related articles

Interleukin-2 receptor-directed therapies for cutaneous lymphomas.

Foss FM, Waldmann TA.

Hematol Oncol Clin North Am. 2003 Dec;17(6):1449-58. Review.PMID: 14710895 [PubMed - indexed for MEDLINE]Related articles

Peripheral T-cell lymphomas: diagnosis and management.

Dearden CE, Foss FM.

Hematol Oncol Clin North Am. 2003 Dec;17(6):1351-66. Review.PMID: 14710889 [PubMed - indexed for MEDLINE]Related articles

Reduced-intensity transplantation for patients with myelodysplastic syndrome achieves durable remission with less graft-versus-host disease.

Chan GW, Foss FM, Klein AK, Sprague K, Miller KB.

Biol Blood Marrow Transplant. 2003 Dec;9(12):753-9.PMID: 14677114 [PubMed - indexed for MEDLINE]Related articles

Extracorporeal photopheresis in the treatment of graft-vs-host disease.

Foss FM.

J Cutan Med Surg. 2003 Jul-Aug;7(4 Suppl):13-7. No abstract available. PMID: 12958702 [PubMed - indexed for MEDLINE]Related articles

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 10-2003. A 72-year-old man with rapidly progressive leukemia, rash, and multiorgan failure.

Foss FM, Aquino SL, Ferry JA.

N Engl J Med. 2003 Mar 27;348(13):1267-75. No abstract available. PMID: 12660391 [PubMed - indexed for MEDLINE]Related articles

Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease.

Chan GW, Gorgun G, Miller KB, Foss FM.

Biol Blood Marrow Transplant. 2003 Mar;9(3):170-6.PMID: 12652467 [PubMed - indexed for MEDLINE]Related articles

Lymphoma of the skin.

Connors JM, Hsi ED, Foss FM.

Hematology Am Soc Hematol Educ Program. 2002:263-82. Review.PMID: 12446427 [PubMed - indexed for MEDLINE]Related articlesFree article

Arginine butyrate increases the cytotoxicity of DAB(389)IL-2 in leukemia and lymphoma cells by upregulation of IL-2Rbeta gene.

Shao RH, Tian X, Gorgun G, Urbano AG, Foss FM.

Leuk Res. 2002 Dec;26(12):1077-83.PMID: 12443879 [PubMed - indexed for MEDLINE]Related articles

Altered biological activity associated with C-terminal modifications of IL-7.

Görgün G, van der Spek J, Cosenza L, Menevse A, Foss F.

Cytokine. 2002 Oct 7;20(1):17-22.PMID: 12441142 [PubMed - indexed for MEDLINE]Related articles

Identification of amplified clonal T cell populations in the blood of patients with chronic graft-versus-host disease: positive correlation with response to photopheresis.

French LE, Alcindor T, Shapiro M, McGinnis KS, Margolis DJ, Porter D, Leonard DG, Rook AH, Foss F.

Bone Marrow Transplant. 2002 Oct;30(8):509-15.PMID: 12379890 [PubMed - indexed for MEDLINE]Related articlesFree article

Diphtheria fusion protein therapy of chemoresistant malignancies.

Frankel AE, Rossi P, Kuzel TM, Foss F.

Curr Cancer Drug Targets. 2002 Mar;2(1):19-36. Review.PMID: 12188918 [PubMed - indexed for MEDLINE]Related articles

Immunomodulatory effects of RXR rexinoids: modulation of high-affinity IL-2R expression enhances susceptibility to denileukin diftitox.

Gorgun G, Foss F.

Blood. 2002 Aug 15;100(4):1399-403.PMID: 12149223 [PubMed - indexed for MEDLINE]Related articlesFree article